MedPath

EGM Analysis in Idiopathic Outflow Tract Ventricular Arrhythmia

Completed
Conditions
Ventricular Outflow Tract Tachycardia
Registration Number
NCT02722577
Lead Sponsor
Abbott Medical Devices
Brief Summary

Investigate the value of unipolar and bipolar electrograms (EGM) for predicting the successful ablation site for idiopathic outflow tract ventricular arrhythmia (OTVA).

Detailed Description

The proposed study aims to evaluate the predictive value of using reversed polarity in adjacent bipolar EGMs (bi-RP method) and unipolar EGM with QS morphology (uni-QS method) for identifying successful ablation site, and evaluate the feasibility of enhancing uni-QS method's performance by using its morphology characteristics such as descending slope and symmetry.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
20
Inclusion Criteria
  • Patients scheduled to undergo ablation for idiopathic OTVA
  • Have the ability to provide informed consent for study participation.
Exclusion Criteria
  • Be currently participating in any other investigational study
  • Be less than 18 years of age
  • Be pregnant
  • Has any other conditions that are not suitable for catheter ablation (including but are not limited to active whole-body infection or sepsis, coagulation or hemorrhage disorder history)

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Percent of Ablation Targets With Termination of the Clinical Ventricular Arrhythmia After RF Energy DeliveryIntraoperative, an average of 2 hours
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath